Cite

HARVARD Citation

    Dulai, P. et al. (2020). A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease. Alimentary pharmacology & therapeutics. 51 (5), pp. 553-564. [Online]. 
  
Back to record